Oscar Health, Inc.
OSCR · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $9,177,941 | $5,862,869 | $4,125,584 | $1,920,961 |
| % Growth | 56.5% | 42.1% | 114.8% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $9,177,941 | $5,862,869 | $4,125,584 | $1,920,961 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1,755,942 | $1,424,763 | $1,419,370 | $265,078 |
| SG&A Expenses | $1,755,942 | $1,424,763 | $1,419,370 | $265,078 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $7,388,573 | $4,705,406 | $3,316,289 | $2,226,463 |
| Operating Expenses | $9,144,515 | $6,130,169 | $4,735,659 | $2,491,541 |
| Operating Income | $33,426 | -$267,300 | -$610,075 | -$570,580 |
| % Margin | 0.4% | -4.6% | -14.8% | -29.7% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | $33,426 | -$267,300 | -$610,075 | -$570,580 |
| Tax Expense | $7,305 | $3,294 | -$523 | $846 |
| Net Income | $25,432 | -$270,728 | -$606,275 | -$572,606 |
| % Margin | 0.3% | -4.6% | -14.7% | -29.8% |
| EPS | 0.11 | -1.22 | -2.87 | -3.19 |
| % Growth | 109% | 57.5% | 10% | – |
| EPS Diluted | 0.096 | -1.22 | -2.87 | -3.19 |
| Weighted Avg Shares Out | 240,386 | 221,655 | 212,475 | 178,967 |
| Weighted Avg Shares Out Dil | 265,853 | 221,655 | 212,475 | 178,967 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $23,734 | $24,603 | $22,623 | $4,720 |
| Depreciation & Amortization | $32,145 | $30,694 | $15,283 | $14,605 |
| EBITDA | $89,305 | -$212,003 | -$572,169 | -$551,255 |
| % Margin | 1% | -3.6% | -13.9% | -28.7% |